These results suggest that, when assessed through bivariate analyses, the genetic variations FAS rs1800682 (A/G) and FASL rs763110 (C/T) may influence the increased expression of FAS and FASL, respectively, and contribute to the severity of COVID-19. This evidence concerns the gene FAS and COVID-19.